DNA Probes Based Diagnostics Market
Request Sample Report
DNA Probes Based Diagnostics Market Size and Growth
The DNA Probes Based Diagnostics market is experiencing substantial growth, driven by advancements in genetic testing and personalized medicine. In 2023, the market size is estimated at approximately $1.5 billion, with a projected CAGR of 10% through 2028, reflecting increasing demand for rapid and accurate diagnostic solutions. Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott Molecular
◍ Beckman Coulter
◍ Becton, Dickinson and Company
◍ Roche
◍ GE Healthcare Life Sciences
◍ Luminex Corporation
◍ QIAGEN
◍ Siemens Healthineers
◍ Thermo Fisher Scientific
The DNA probes-based diagnostics market features key players like Abbott Molecular, Roche, and Thermo Fisher Scientific, which develop innovative assays for genetic testing, infectious diseases, and oncology. Their advancements enhance detection accuracy and speed, driving market growth. Notable sales revenues include Thermo Fisher at approximately $30 billion and Roche at $68 billion. Request Sample Report
Market Segmentation
By Application
◍ Infectious Diseases
◍ Cancer
◍ Genetic Predisposition
◍ Identity or Forensics
◍ Others
By Product
◍ Genomic Probe
◍ cDNA Probe
◍ Oligonucleotide Probe
Request Sample Report
Market Growth
Request Sample Report
$ 21.14 Billion
